CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY Nurse Edition. 24
Pages: 1  2  3  
Next
Integrative Oncology 

Ginger

By Julie L. Ryan, PhD, MPH
Associate Professor, Dermatology and
Radiation Oncology

Gary R. Morrow, PhD, MS
Professor of Radiation Oncology and
Psychiatry Director, University of Rochester
Cancer Center Community Clinical

Oncology Program Research Base
University of Rochester Medical Center and
Wilmot Cancer Center, Rochester, New York

Guest Editors
Debra Barton, PhD, RN, AOCN, FAAN
Susan Bauer-Wu, PhD, RN, FAAN | February 16, 2010

Ginger, the rhizome of Zingiber officinale Roscoe, is best known for its role as a flavoring agent for food in Asian and Indian recipes. Since the 16th century, ginger has been used to treat various medical ailments and conditions, including migraines, arthritis, gingivitis, stroke, ulcers, constipation, diabetes, and nausea.[1,2] It is even believed to help with symptoms of the common cold or influenza.[2] In 1807, William Roscoe, an English botanist, named the ginger plant “Zingiber” after the Sanskrit word for “horn-shaped.” The ginger family of plants consists of more than 1,200 species in 53 different genera.

It is important to note that not all ginger is the same. Genus Zingiber includes 85 species of aromatic herbs from East Asia and tropical Australia. Ginger (Zingiber officinale Roscoe) is often called “ginger root.” The major world producers of ginger (Zingiber officinale Roscoe) include China, India, and Indonesia.[2,3] While Thai ginger and wild ginger are in the ginger family, they are not the same genus or species of ginger as ginger root. For the purpose of this article, “ginger” refers to Zingiber officinale Roscoe.

Ginger is composed of volatile oils (1–3%) and nonvolatile pungent compounds. The oils are responsible for its distinct aroma, and the pungent compounds account for the “hot” or “spicy” sensation it produces in the mouth.[1] The most abundant components of the volatile oils include zingeberene (35%), cucumene (18%), and farnesene (35%). The most abundant pungent compounds, as well as the biologically active constituents of ginger root, include gingerols, shogaols, paradols, and zingerone. Gingerols are the major active component in fresh ginger and shogaols are the more abundant active component in dried ginger. Gingerol becomes shogaol upon dehydration of fresh ginger.[1] Overall, the major biological constituents of ginger (ranging from highest to lowest amounts by weight) are: 6-gingerol, 6-paradol, 6-shogaol, and zingerone.[1,2,4]

Owing to its medicinal properties, ginger has gained considerable attention as a dietary supplement in the United States and Europe. To date, research studies have shown biological activities of ginger to include anti-inflammatory, antioxidant, antiemetic, antiapoptotic, antihyperglycemic, and anticancer properties. Most recently, ginger was shown to improve wound healing in combination with curcumin, a member of the ginger family and another spice with powerful antioxidant and anti-inflammatory capabilities.[5]

How Is It Currently Used?

Ginger is typically consumed in the form of fresh, dried powder; an encapsulated powder or liquid extract; slices preserved in syrup; dried and preserved with a sugar coating (crystallized ginger); or as a tea flavoring.[1] Medicinally, ginger is used primarily to quell nausea associated with motion sickness, pregnancy, the postoperative period, and cancer chemotherapy.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Trudy Fittler | April 09, 2010 6:53 AM EDT

My son has been diagnosed with Medullablastoma(11/1/2010) we have been using ginger drinks during radiation and afterwards and it does seem to help.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy